Trade Show News

Today is July 10, 2024. All times in Eastern Daylight Time.

Doublepoint’s WowMouse AR Enhances Users’ Experience on Magic Leap 2, Debuts at AWE 2024 as First Wrist-Worn Gesture Control for Augmented Reality

06/17/2024 - 09:25 AM

BUSINESS WIRE
Unity Showcases Customer Experiences Driving 3D Innovation Across Industries at the 2024 Augmented World Expo

06/17/2024 - 09:00 AM

BUSINESS WIRE
CuriosityStream Inc. to Participate in the Singular Research Summer Solstice Conference in New York City

06/17/2024 - 09:00 AM

BUSINESS WIRE
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

06/17/2024 - 08:15 AM

BUSINESS WIRE
pSemi Announces New Packaged 30 GHz High-Performance SP4T RF Switch

06/17/2024 - 08:00 AM

BUSINESS WIRE
Booz Allen Convenes Experts to Discuss Challenges at the Heart of the Defense Warfighting Mission

06/17/2024 - 08:00 AM

BUSINESS WIRE
SkyWater Announces Participation in 16th Annual CEO Investor Summit

06/17/2024 - 07:05 AM

BUSINESS WIRE
Teledyne FLIR Defense Announces New SUGV 325 Portable, Modular Robot

06/17/2024 - 01:00 AM

BUSINESS WIRE
Celltrion präsentiert auf dem EULAR 2024 vielversprechende Ergebnisse der Phase-III-Studie für CT-P47, einem Biosimilar-Kandidaten von RoActemra® (Tocilizumab) bei Patienten mit rheumatoider Arthritis (RA)

06/16/2024 - 08:14 PM

BUSINESS WIRE
Celltrion laat veelbelovende resultaten zien in fase III-studie voor CT-P47, een biosimilar-kandidaat van RoActemra ® (tocilizumab) bij patiënten met reumatoïde artritis (RA) op EULAR 2024

06/16/2024 - 08:14 PM

BUSINESS WIRE
Celltrion présente à EULAR 2024 les résultats prometteurs d’une étude de phase III sur le CT-P47, un candidat biosimilaire de RoActemra® (tocilizumab), menée sur des patients atteints de polyarthrite rhumatoïde (PR)

06/16/2024 - 08:14 PM

BUSINESS WIRE
Celltrion presenta risultati promettenti all'EULAR 2024 nello studio di fase III per CT-P47, candidato biosimilare di RoActemra® (tocilizumab) in pazienti affetti da artrite reumatoide (AR)

06/16/2024 - 08:13 PM

BUSINESS WIRE
Igloo Coolers präsentiert seine Produkte zur aktiven Kühlung auf der Spoga+Gafa

06/16/2024 - 05:44 AM

BUSINESS WIRE
Igloo Coolers Showcases Its Active Cooling Products at Spoga+Gafa

06/16/2024 - 02:00 AM

BUSINESS WIRE
伊頓的創新安全解決方案有助於加速電動汽車轉型

06/14/2024 - 09:42 AM

BUSINESS WIRE
伊顿的创新安全解决方案有助于加速电动汽车转型

06/14/2024 - 09:42 AM

BUSINESS WIRE
ViewSonic Announces 92-Inch, 5K, Ultra-Wide Commercial Display Optimized for Microsoft Teams Rooms and Digital Signage

06/14/2024 - 08:03 AM

BUSINESS WIRE
Celltrion 賽特瑞恩在 EULAR 2024 上展示了 CT-P47（RoActemra® [托珠單抗]的生物相似藥）治療類風濕性關節炎患者的 III 期研究取得的積極成果

06/14/2024 - 02:18 AM

BUSINESS WIRE
Mitsubishi Electric to Ship Samples of GaN MMIC Power Amplifier for Ka-band SATCOM Earth Stations

06/13/2024 - 10:10 PM

BUSINESS WIRE
セルトリオン、EULAR 2024にて、関節リウマチ（RA）患者向けACTEMRA/RoActemra（トシリズマブ）のバイオシミラー候補であるCT-P47の第III相試験の有望な結果を示す

06/13/2024 - 06:01 PM

BUSINESS WIRE
Celltrion presenta en EULAR 2024 los alentadores resultados del estudio de fase III de CT-P47, un candidato a biosimilar de RoActemra® (tocilizumab) en pacientes con artritis reumatoide (AR)

06/13/2024 - 06:01 PM

BUSINESS WIRE
Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024

06/13/2024 - 06:01 PM

BUSINESS WIRE
MACOM to Showcase Extensive RF and Microwave Capabilities and Foundry Services at IMS2024

06/13/2024 - 04:02 PM

BUSINESS WIRE
Connectivity Unleashed: pSemi Demonstrates Innovation in Action with High-Performance RF Solutions at IMS 2024

06/13/2024 - 03:41 PM

BUSINESS WIRE
Vizient Showcases Vizient Vulnerability Index™ on Capitol Hill

06/13/2024 - 03:36 PM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 12 13

Next »

Search